TITLE

Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment

AUTHOR(S)
Loewen, Gregory; Natarajan, Nachimuthu; Dongfeng Tan; Nava, Enriqueta; Klippenstein, Donald; Mahoney, Martin; Cummings, Michael; Reid, Mary; Tan, Dongfeng
PUB. DATE
April 2007
SOURCE
Thorax;Apr2007, Vol. 62 Issue 4, p335
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: This is a preliminary report of an ongoing prospective bimodality lung cancer surveillance trial for high-risk patients. Bimodality surveillance incorporates autofluorescence bronchoscopy (AFB) and spiral CT (SCT) scanning in high-risk patients as a primary lung cancer surveillance strategy, based entirely on risk factors. AFB was used for surveillance and findings were compared with conventional sputum cytology for the detection of malignancy and pre-malignant central airway lesions.Methods: 402 patients registering at Roswell Park Cancer Institute were evaluated with spirometric testing, chest radiography, history and physical examination, of which 207 were deemed eligible for the study. For eligibility, patients were required to have at least two of the following risk factors: (1) > or =20 pack year history of tobacco use, (2) asbestos-related lung disease on the chest radiograph, (3) chronic obstructive pulmonary disease with a forced expiratory volume in 1 s (FEV(1)) <70% of predicted, and (4) prior aerodigestive cancer treated with curative intent, with no evidence of disease for >2 years. All eligible patients underwent AFB, a low-dose SCT scan of the chest without contrast, and a sputum sample was collected for cytological examination. Bronchoscopic biopsy findings were correlated with sputum cytology results, SCT-detected pulmonary nodules and surveillance-detected cancers. To date, 186 have been enrolled with 169 completing the surveillance procedures.Results: Thirteen lung cancers (7%) were detected in the 169 subjects who have completed all three surveillance studies to date. Pre-malignant changes were common and 66% of patients had squamous metaplasia or worse. Conventional sputum cytology missed 100% of the dysplasias and 68% of the metaplasias detected by AFB, and failed to detect any cases of carcinoma or carcinoma-in-situ in this patient cohort. Sputum cytology exhibited 33% sensitivity and 64% specificity for the presence of metaplasia. Seven of 13 lung cancers (58%) were stage Ia or less, including three patients with squamous cell carcinoma. Patients with peripheral pulmonary nodules identified by SCT scanning of the chest were 3.16 times more likely to exhibit pre-malignant changes on AFB (p<0.001).Conclusion: Bimodality surveillance will detect central lung cancer and pre-malignancy in patients with multiple lung cancer risk factors, even when conventional sputum cytology is negative. AFB should be considered in high-risk patients, regardless of sputum cytology findings.
ACCESSION #
25021018

 

Related Articles

  • High resolution spiral CT for determining the malignant potential of solitary pulmonary nodules: refining and testing the test. Harders, Stefan Walbom; Madsen, Hans Henrik; Rasmussen, Torben Riis; Hager, Henrik; Rasmussen, Finn // Acta Radiologica;May2011, Vol. 52 Issue 4, p401 

    Background: A solitary pulmonary nodule (SPN) may represent early stage lung cancer. Lung cancer is a devastating disease with an overall 5-year mortality rate of approximately 84% but with early detection and surgery as low as 47%. Currently a contrast-enhanced multiple-row detector CT (MDCT)...

  • A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial). Halmos, Balazs // Current Medical Literature: Lung Cancer;2013, Vol. 7 Issue 2, p53 

    The article discusses a research on the treatment of early-stage non-small-cell lung cancer (NSCLC). It references a study "A Randomised Trial Comparing Preoperative to Perioperative Chemotheraphy in Early-Stage Non-Small-Cell Lung Cancer (IFCT 0002 Trial)," by V. Westeel and colleagues, which...

  • Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review. Hotta, Katsuyuki; Kiura, Katsuyuki; Fujiwara, Yoshiro; Takigawa, Nagio; Hisamoto, Akiko; Ichihara, Eiki; Tabata, Masahiro; Tanimoto, Mitsune // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: In advanced non-small-cell lung cancer (NSCLC), with the increasing number of active compounds available in salvage settings, survival after progression to first-line chemotherapy seems to have improved. A literature survey was conducted to examine whether survival post-progression...

  • Der Granularzelltumor der Luftwege -- eine seltene. Schramm, A.; Schaeper, F.; Merk, J.; Klemm, W.; Leschber, G. // GMS Thoracic Surgical Science;2009, Vol. 6, p1 

    Introduction: Pulmonary lesions are often detected in routine x-rays, leading to a more invasive diagnostic pathway. Occasionally rare tumor entities are encountered. Case report: We report a patient, who had a check-up where chest xray showed a pulmonary lesion. The following CT imaging...

  • Virtual bronchoscopy using FDG-PET/CT images for the evaluation of lung cancer. YILDIRIM, D.; TAMAM, M.; SANLI, Y.; OZGUL, M. A.; SOMAY, A. // European Review for Medical & Pharmacological Sciences;Dec2012, Vol. 16 Issue 14, p1951 

    PURPOSE: We aimed to put forward the contribution of virtual bronchoscopy in the determination and diagnosis of tracheobronchial system pathologies. We compared the data obtained from PET/CT and virtual bronchoscopy (VB) with the fiberoptic bronchoscopy (FOB) data of the cases with a diagnosis...

  • THE ROLE OF ENDOBRONCHIAL ULTRASOUND GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION FOR THE DIAGNOSIS OF PERIBRONCHIAL LESIONS. Cömert, Sevda Şener; Çağlayan, Benan; Ece, Dilek; Kıral, Nesrin; Fidan, Ali; Saraç, Gülşen // Turkish Respiratory Journal / Solunum Dergisi;2013 Supplement, Vol. 15, p40 

    Aim: The diagnosis of peribronchial lesions which do not have endobronchial component visible on bronchoscopy may be difficult. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), which is useful for the diagnosis of mediastinal and hilar lymph nodes, can be an...

  • Earlier Cancer Detection.  // Prevention;Sep2008, Vol. 60 Issue 9, p39 

    The article offers news briefs on early cancer detection, including the development of a lung cancer test by U.S. doctors at the University of Texas, an ultrasound device developed by Norwegian researchers being used in clinical trials for the early detection of tiny tumors, and a laser light...

  • Benefits of Screening for Lung Cancer With CT Are Not Proven.  // Ascribe Newswire: Medicine;6/10/2004, p28 

    The medical literature does not support the widely held belief that an advanced screening technique called computed tomography (CT) can save lives simply because it detects lung cancers at a smaller size than other screening techniques, according to researchers at Duke University Medical Center...

  • Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests. Baker, Stuart G.; Kramer, Barnett S. // Journal of Medical Screening;Mar2008, Vol. 15 Issue 1, p18 

    Objectives: When evaluating screening for the early detection of cancer, it is important to estimate both harms and benefits. One common harm is a false-positive (FP), which is a positive screening result, perhaps followed by an invasive test, with no cancer detected on the diagnostic work-up or...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics